About
Small Molecules, Protein Degradation
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
1,228
By Phase
PHASE1: 7
By Status
RECRUITING: 4COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06717269Lead Sponsor
Relative Bioavailability of NX-5948 Tablets Vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets
PHASE1Recruiting
18 participants
Started: Nov 30, 2024 · Completed: Mar 31, 2025
NCT06691828Lead Sponsor
Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948
PHASE1Completed
8 participants
Started: Nov 1, 2024 · Completed: Dec 5, 2024
NCT06593457Lead Sponsor
A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects
PHASE1Completed
32 participants
Started: Aug 20, 2024 · Completed: Nov 14, 2024
NCT05131022Lead Sponsor
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
PHASE1Recruiting
572 participants
Started: Apr 13, 2022 · Completed: Jan 31, 2028
NCT05107739Lead Sponsor
A Study of DeTIL-0255 in Adults With Advanced Malignancies
PHASE1Terminated
5 participants
Started: Dec 22, 2021 · Completed: May 9, 2023
Locations (1)
Headquarters
San Francisco, CA, United States
Map
Loading map...